Jill Carroll

Jill Carroll

Signal active

Partner

Bio

Jill joined SR One in 2011 with a background in biotech partnering and commercial development.

Prior to SR One, Jill was responsible for Corporate Development at Dynavax Technologies, where she was involved in multiple pharma partnering deals as well as substanial private and public financings.

Previously, Jill was a consultant specializing in health care at Clearview Projects and Mercer Management Consulting.

Jill received her BS in Chemistry from Duke University, and her MS in Biochemistry, Cellular and Molecular Biology from Johns Hopkins University.

Location

N/A

Social

Primary Organization

SR One

SR One

Founded

1985

Investment

190

Lead investment

60

Exits

58

Employees

1-10

Industry

Financial Services, Venture Capital, Finance, Health Care

Jobs history

3

Avalyn Pharma

Board Member

Invalid date - Current

Odyssey Therapeutics

Board Member

Invalid date - Current

Board Member

2020 - Current

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Jill Carroll is the Partner at SR One, based in United States, North America. With a background in Financial Services, Jill Carroll has a rich history of leadership and innovation. Jill Carroll studied BS Chemistry @ Duke University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

N/A

Number of investment

1

Number of exits

0

Personal investment

0

There is no personal investment available on this profile

Partner investment

6

Annouced DateOrganization NameFunding RoundInvestor NameMoney Raised
Nov 29, 2021-
Series C - HotSpot Therapeutics
SR One
100.0M
Dec 07, 2021
Odyssey Therapeutics Odyssey Therapeutics
Series A - Odyssey Therapeutics
Odyssey Therapeutics SR One
218.0M
Oct 13, 2022
Odyssey Therapeutics Odyssey Therapeutics
Series B - Odyssey Therapeutics
Odyssey Therapeutics SR One
168.0M
Sep 27, 2023
Avalyn Pharma Avalyn Pharma
Series C - Avalyn Pharma
Avalyn Pharma SR One
175.0M

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.